Transcriptomic profiling reveals p53 as a key regulator of doxorubicin-induced cardiotoxicity
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2058-7716
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Transcriptomic profiling reveals p53 as a key regulator of doxorubicin-induced cardiotoxicity ; volume:5 ; number:1 ; day:12 ; month:6 ; year:2019 ; pages:1-11 ; date:12.2019
Cell death discovery ; 5, Heft 1 (12.6.2019), 1-11, 12.2019
- Urheber
-
McSweeney, K. Melodi
Bozza, William P.
Alterovitz, Wei-Lun
Zhang, Baolin
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41420-019-0182-6
- URN
-
urn:nbn:de:101:1-2019090609070880959764
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:26 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- McSweeney, K. Melodi
- Bozza, William P.
- Alterovitz, Wei-Lun
- Zhang, Baolin
- SpringerLink (Online service)
Ähnliche Objekte (12)
Rifampicin efficacy against doxorubicin-induced cardiotoxicity in mice
Diazoxide protects against doxorubicin-induced cardiotoxicity in the rat
Doxorubicin-induced cardiotoxicity in adult Indian patients on chemotherapy
Sex Differences in Doxorubicin‐Induced Cardiotoxicity: Insights from Transcriptome Analysis
Protective effect of silymarin on doxorubicin-induced cardiotoxicity in rats
Tripartite motif 25 ameliorates doxorubicin-induced cardiotoxicity by degrading p85α
The significance of the apelinergic system in doxorubicin-induced cardiotoxicity
PFKM inhibits doxorubicin-induced cardiotoxicity by enhancing oxidative phosphorylation and glycolysis
Shikonin alleviates doxorubicin-induced cardiotoxicity via Mst1/Nrf2 pathway in mice
The Role of AMPK Activation for Cardioprotection in Doxorubicin-Induced Cardiotoxicity
Cardiomyocyte-specific disruption of Cathepsin K protects against doxorubicin-induced cardiotoxicity
GAS-STING signaling plays an essential pathogenetic role in Doxorubicin-Induced Cardiotoxicity
Rifampicin efficacy against doxorubicin-induced cardiotoxicity in mice
Diazoxide protects against doxorubicin-induced cardiotoxicity in the rat
Doxorubicin-induced cardiotoxicity in adult Indian patients on chemotherapy
Sex Differences in Doxorubicin‐Induced Cardiotoxicity: Insights from Transcriptome Analysis
Protective effect of silymarin on doxorubicin-induced cardiotoxicity in rats
Tripartite motif 25 ameliorates doxorubicin-induced cardiotoxicity by degrading p85α
The significance of the apelinergic system in doxorubicin-induced cardiotoxicity
PFKM inhibits doxorubicin-induced cardiotoxicity by enhancing oxidative phosphorylation and glycolysis
Shikonin alleviates doxorubicin-induced cardiotoxicity via Mst1/Nrf2 pathway in mice
The Role of AMPK Activation for Cardioprotection in Doxorubicin-Induced Cardiotoxicity
Cardiomyocyte-specific disruption of Cathepsin K protects against doxorubicin-induced cardiotoxicity
GAS-STING signaling plays an essential pathogenetic role in Doxorubicin-Induced Cardiotoxicity
Rifampicin efficacy against doxorubicin-induced cardiotoxicity in mice
Diazoxide protects against doxorubicin-induced cardiotoxicity in the rat
Doxorubicin-induced cardiotoxicity in adult Indian patients on chemotherapy
Sex Differences in Doxorubicin‐Induced Cardiotoxicity: Insights from Transcriptome Analysis
Protective effect of silymarin on doxorubicin-induced cardiotoxicity in rats
Tripartite motif 25 ameliorates doxorubicin-induced cardiotoxicity by degrading p85α
The significance of the apelinergic system in doxorubicin-induced cardiotoxicity
PFKM inhibits doxorubicin-induced cardiotoxicity by enhancing oxidative phosphorylation and glycolysis
Shikonin alleviates doxorubicin-induced cardiotoxicity via Mst1/Nrf2 pathway in mice
The Role of AMPK Activation for Cardioprotection in Doxorubicin-Induced Cardiotoxicity
Cardiomyocyte-specific disruption of Cathepsin K protects against doxorubicin-induced cardiotoxicity